Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Understand when to opt for long term investing over short term to maximize your investment returns. Discover the key factors influencing your decision.
28,006 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
As AI demand grows, one data-center play stands out for potential upside. This piece breaks down the catalysts, risks...
Retirees want sunshine, security, and smart money. This coastal florida city delivers on climate and cost, plus inves...
The EV market is shifting quickly, and two growth stocks sit at opposite ends of the spectrum: Tesla and Rivian. This...
Sweetgreen faced a sharp stock drop this week as traffic and cost pressures weighed on its growth story. This guide b...
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Micron just beat earnings, but the stock didn’t soar. This article breaks down what happened, how AI demand, margins,...
In this stock market today update, Intel pulls back as AI bubble risk concerns rise, even as AI-driven momentum suppo...
As butterfly (BFLY) prepares for 2025 earnings, investors want clarity on growth, margins, and cash runway. This arti...
The U.S. government withdraws a global AI chip licensing plan, removing near-term constraints on Nvidia's internation...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
A major hedge fund shift has sparked fresh questions about Privia Health. This article dives into what the move signa...